Mycoses
Information
- Disease name
- Mycoses
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00686621 | Approved for marketing | Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113) | |||
| NCT00000826 | Completed | Phase 1 | Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites | May 1999 | |
| NCT00001280 | Completed | Phase 2 | Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease | January 1991 | March 2001 |
| NCT00001757 | Completed | Phase 3 | An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections | November 1997 | July 2000 |
| NCT00001790 | Completed | Phase 1 | Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia | October 1998 | September 2000 |
| NCT00001810 | Completed | Phase 3 | An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections | April 1999 | October 2000 |
| NCT00001937 | Completed | Phase 3 | Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients | November 1999 | December 2000 |
| NCT00001940 | Completed | Phase 3 | Voriconazole to Treat Fungal Infections | December 1999 | July 2001 |
| NCT00002038 | Completed | N/A | Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy | ||
| NCT00002122 | Completed | Phase 3 | A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients | ||
| NCT00002277 | Completed | Phase 3 | A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections | ||
| NCT00002325 | Completed | N/A | A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common | ||
| NCT00005912 | Completed | Phase 1 | Voriconazole to Prevent Systemic Fungal Infections in Children | June 2000 | January 2001 |
| NCT00015665 | Completed | Phase 3 | Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections | April 2001 | March 2003 |
| NCT00034632 | Completed | Phase 3 | Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095) | April 2001 | March 2007 |
| NCT00034645 | Completed | Phase 3 | Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease | January 1999 | February 2003 |
| NCT00034658 | Completed | Phase 3 | Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041) | December 1998 | March 2002 |
| NCT00034671 | Completed | Phase 2 | PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893) | January 2001 | March 2002 |
| NCT00177788 | Completed | Voriconazole as Prophylaxis for Liver Transplant Recipients | September 2005 | August 2012 | |
| NCT00336531 | Completed | Phase 4 | Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation | April 2006 | October 2008 |
| NCT00413218 | Completed | Phase 3 | Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections | March 8, 2007 | March 3, 2015 |
| NCT00550732 | Completed | Phase 2 | A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2) | December 2007 | November 2012 |
| NCT02244606 | Completed | Phase 2 | Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis | September 2014 | August 2016 |
| NCT01772212 | Completed | Phase 1 | Bioequivalence Study for Terbinafine 250 mg | February 24, 2011 | March 15, 2011 |
| NCT00000676 | Completed | Phase 3 | Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) | November 1993 | |
| NCT02492802 | Completed | Effect of Inflammation on Pharmacokinetics of Posaconazole | August 13, 2015 | August 1, 2017 | |
| NCT02683642 | Completed | Invasive Mould Infections in Indian ICUs - Descriptive Epidemiology, Management and Outcome | April 2016 | September 30, 2017 | |
| NCT02733432 | Completed | Phase 2 | RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections | June 8, 2016 | December 23, 2016 |
| NCT02734862 | Completed | Phase 2 | CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension | July 26, 2016 | July 2019 |
| NCT02888197 | Completed | Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization | August 16, 2016 | March 15, 2017 | |
| NCT03429023 | Completed | Descriptive Epidemiology on Management of Mucormycosis | April 1, 2016 | September 30, 2017 | |
| NCT03667690 | Completed | Phase 3 | Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis | October 7, 2018 | October 7, 2021 |
| NCT04265521 | Completed | N/A | Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet | March 3, 2020 | June 25, 2020 |
| NCT00726609 | Completed | Post-marketing Surveillance Study of Invasive Mycosis With Posaconazole (Study P04641) | January 2006 | July 2008 | |
| NCT00784368 | Completed | Phase 3 | A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection | January 2008 | May 2009 |
| NCT00841971 | Completed | Phase 4 | Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients | February 2010 | May 2014 |
| NCT00890708 | Completed | N/A | Therapeutic Drug Monitoring of Voriconazole | November 2008 | February 2012 |
| NCT00896493 | Completed | Phase 2 | Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma | May 2009 | December 2022 |
| NCT01058174 | Completed | Phase 3 | Liver Transplant European Study Into the Prevention of Fungal Infection | December 15, 2009 | May 3, 2012 |
| NCT01122368 | Completed | Phase 2 | A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects | July 13, 2010 | December 15, 2011 |
| NCT01232504 | Completed | Phase 4 | Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCT | September 2009 | June 2013 |
| NCT01254318 | Completed | Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501) | March 2013 | November 2014 | |
| NCT01307930 | Completed | Phase 4 | Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations | January 2011 | November 2012 |
| NCT00342589 | Recruiting | New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia | September 28, 1999 | ||
| NCT01829204 | Recruiting | Prospective Data Bank Creation to Study Vaginal Conditions | April 2013 | December 2027 | |
| NCT04157465 | Recruiting | N/A | Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients | November 7, 2019 | June 30, 2024 |
| NCT04368559 | Recruiting | Phase 3 | Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation | May 11, 2020 | August 2024 |
| NCT03923010 | Terminated | Phase 4 | A Study of Itraconazole in the Management of Superficial Fungal Infections in India | August 6, 2019 | March 27, 2020 |
| NCT01260974 | Unknown status | Phase 2 | Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients | May 2009 | November 2012 |
| NCT00673348 | Unknown status | Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations | May 2008 | April 2010 | |
| NCT02676570 | Unknown status | Validation of Pathologic Diagnosis of Invasive Fungal Infection by Molecular Method | February 2016 | December 2017 | |
| NCT01315925 | Unknown status | Pre-hospital Risk Factors for Invasive Fungal Infection | January 2010 | ||
| NCT00704951 | Withdrawn | Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections in Immuncompromised Patients in Austria (Study P05532)(WITHDRAWN) | July 2008 | June 2011 |
- ICD10 preferred id (Insert disease from ICD10)
- D0000615
- ICD10 class code (Insert disease from ICD10)
- MeSH unique ID (MeSH (Medical Subject Headings))
- D009181